![Quiver Logo](/static/img/logo-icon.png)
![TNDM logo](https://quiver-logos.s3.us-east-2.amazonaws.com/tndm.png)
Tandem Diabetes Care, Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TNDM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of TNDM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TNDM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to TNDM
Recent picks made for TNDM stock on CNBC
ETFs with the largest estimated holdings in TNDM
Flights by private jets registered to TNDM
![Quiver Logo](/static/img/logo-icon.png)